Global Treatment-Resistant Depression Market Share

Market Share of Global Treatment-Resistant Depression Industry

The Treatment- Resistant Depression market is fragmented and competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are AstraZeneca, Pfizer, Inc, GlaxoSmithKline, Eli Lilly and Company, Bristol-Myers Squibb Company, Forest Laboratories, Johnson and Johnson, Schering Plough Corporation, Vistagen Therapeutics, Inc, Wyeth, and Others

Treatment-Resistant Depression Market Leaders

1. AstraZeneca

2. Pfizer

3. GlaxoS

4. Eli Lilly and Company

5. Johnson and Johnson

*Disclaimer: Major Players sorted in no particular order